[PDF] oapen.org

[PDF][PDF] Glycaemic Control in Diabetes

D Müller-Wieland, J Brandts, M Verket… - … and Treatment of …, 2021 - library.oapen.org
Reduction of glucose is the hallmark of diabetes therapy proven to reduce microand macro-
vascular risk in patients with type 1 diabetes. However glucoselowering efficacy trials in type …
被引用次数：3 相关文章

Glycaemic Control in Diabetes

D Müller-Wieland, J Brandts… - Handbook of …, 2022 - pubmed.ncbi.nlm.nih.gov
Reduction of glucose is the hallmark of diabetes therapy proven to reduce micro-and macro-
vascular risk in patients with type 1 diabetes. However glucose-lowering efficacy trials in …
[PDF] oapen.org

[PDF][PDF] Glycaemic Control in Diabetes

D Müller-Wieland, J Brandts, M Verket… - … and Treatment of …, 2021 - library.oapen.org
Reduction of glucose is the hallmark of diabetes therapy proven to reduce microand macro-
vascular risk in patients with type 1 diabetes. However glucoselowering efficacy trials in type …
[PDF] academia.edu

[PDF][PDF] Glycaemic Control in Diabetes

D Müller-Wieland, J Brandts, M Verket… - … and Treatment of …, 2021 - academia.edu
Reduction of glucose is the hallmark of diabetes therapy proven to reduce microand macro-
vascular risk in patients with type 1 diabetes. However glucoselowering efficacy trials in type …
[PDF] uzh.ch

[PDF][PDF] Glycaemic Control in Diabetes

D Müller-Wieland, J Brandts, M Verket, N Marx… - … and Treatment of …, 2021 - zora.uzh.ch
Reduction of glucose is the hallmark of diabetes therapy proven to reduce microand macro-
vascular risk in patients with type 1 diabetes. However glucoselowering efficacy trials in type …

Glycaemic Control in Diabetes

D Müller-Wieland, J Brandts, M Verket… - … and Treatment of …, 2022 - books.google.com
Reduction of glucose is the hallmark of diabetes therapy proven to reduce microand macro-
vascular risk in patients with type 1 diabetes. However glucoselowering efficacy trials in type …
[HTML] nih.gov

[HTML][HTML] Glycaemic Control in Diabetes

D Müller-Wieland, J Brandts, M Verket… - … and Treatment of …, 2021 - ncbi.nlm.nih.gov
Reduction of glucose is the hallmark of diabetes therapy proven to reduce micro-and macro-
vascular risk in patients with type 1 diabetes. However glucose-lowering efficacy trials in …
[HTML] europepmc.org

[HTML][HTML] Glycaemic Control in Diabetes

D Müller-Wieland, J Brandts, M Verket, N Marx… - 2022 - europepmc.org
Reduction of glucose is the hallmark of diabetes therapy proven to reduce micro-and macro-
vascular risk in patients with type 1 diabetes. However glucose-lowering efficacy trials in …
[HTML] springer.com

[HTML][HTML] Glycaemic Control in Diabetes

D Müller-Wieland, J Brandts, M Verket, N Marx… - … and Treatment of …, 2021 - Springer
Reduction of glucose is the hallmark of diabetes therapy proven to reduce micro-and macro-
vascular risk in patients with type 1 diabetes. However glucose-lowering efficacy trials in …
[HTML] europepmc.org

[HTML][HTML] Glycaemic Control in Diabetes

D Müller-Wieland, J Brandts, M Verket, N Marx… - 2022 - europepmc.org
Reduction of glucose is the hallmark of diabetes therapy proven to reduce micro-and macro-
vascular risk in patients with type 1 diabetes. However glucose-lowering efficacy trials in …